Aztreonam

氨曲南

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAztreonam
Drug Alias Name安曲南aztreonamumaztreonam曲氨南噻肟单酰胺菌素 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLower Respiratory Tract InfectionsBartholinitisAcute bacterial skin and skin structure infections +[29] 
Global Approved IndicationsBartholinitisUterine CervicitisCystitis +[19] 
Approved Indications in ChinaGram-Negative Bacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1987/03/01
Country/TerritoryCzechiaBulgariaUnited States +[25] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncPfizer IncHospira Australia Pty Ltd +[8] 
Inactive CompaniesVirginia Commonwealth UniversityUniversity Of Washington
Active IndicationsLower Respiratory Tract InfectionsBartholinitisUterine Cervicitis +[21] 
Inactive IndicationsAcute bacterial skin and skin structure infectionsRespiratory Tract DiseasesPharyngeal Diseases +[8] 

Other Information

ATC CodeJ01DF01
Related LinksWikipediaDrugBankKEGG